Introduction
Regulated degradation of intracellular proteins is essential for protein quality control in both eubacteria and eukaryotes. The N-end rule pathway, one of the most prevalent proteolytic pathways, functions in the in vivo half-life control of selected proteins, by destroying them according to the N-terminal residue (Varshavsky, 1996 (Varshavsky, , 2003 . In eukaryotes, the N-end rule pathway is part of the ubiquitin (Ub) system (Hu et al, 2005; Nandi et al, 2006) , which controls peptide import (Turner et al, 2000; Du et al, 2002) , chromosomal segregation fidelity (Rao et al, 2001) , apoptosis regulation (Ditzel et al, 2003; Varshavsky, 2003) , and nitric oxide detection (Hu et al, 2005) . In eukaryotes, the destabilizing N-terminal residues are hierarchical. The primary destabilizing residues are categorized into two types: the type-1 destabilizing residues are basic (Arg, Lys, or His), whereas the type-2 residues are bulky and hydrophobic (Phe, Leu, Trp, Tyr, or Ile) . Multiple E3 Ub ligases (N-recognins) recognize these N-terminal residues, and conjugate a poly-Ub chain to the target protein. The resulting ubiquitylated proteins are thereafter progressively degraded by the 26S proteasome in an ATP-dependent manner. The secondary destabilizing N-terminal residues, Asp and Glu, are recognized by ArgtRNA-protein transferase (R-transferase), which conjugates an arginine, the primary destabilizing residue, to them. The N-terminal Asn and Gln are tertiary destabilizing residues, in that they are deaminated to yield the secondary destabilizing N-termini of Asp and Glu, respectively. Recently, N-terminal Cys and oxidized Cys residues have also been reported to behave as tertiary and secondary destabilizing residues, respectively, in mammals (Kwon et al, 2002; Hu et al, 2005) . Thus, the functions of the N-end rule pathway have been well elucidated in eukaryotes (Hu et al, 2005) , whereas they still remain unknown in eubacteria.
Eubacteria have an analogous, but Ub-independent, N-end rule pathway (Tobias et al, 1991; Shrader et al, 1993) . As in eukaryotes, the destabilizing residues in bacteria are also hierarchical. In Escherichia coli, the primary destabilizing N-terminal residues are Leu, Phe, Trp, and Tyr. Proteins with these N-terminal residues are degraded by ClpAP, a proteasome-like protease consisting of the AAA þ chaperone ClpA and ClpP peptidase (ClpAP) (Tobias et al, 1991) . Recently, the ClpAP-specific adaptor, ClpS, was identified as an N-recognin, an essential component of the pathway (Erbse et al, 2006) . ClpS shares secondary structural features with UBR1, the E3 Ub ligase of the eukaryotic N-end rule pathway (Lupas and Koretke, 2003) , and binds to a primary destabilizing residue of a substrate to deliver it to the ClpAP protease for degradation (Erbse et al, 2006) . In E. coli, the secondary destabilizing N-terminal residues are Arg and Lys. These N-terminal residues are recognized by leucyl/phenylalanyl-tRNA-protein transferase (L/F-transferase), which conjugates leucine or phenylalanine to the N-terminal Arg or Lys, followed by ClpS recognition. However, the physiological functions of the eubacterial N-end rule pathway remain to be elucidated.
There are several similarities between the eukaryotic and eubacterial N-end rule pathways, such as the hierarchic structure of the destabilizing N-terminal residues, the require-ment of the specific N-recognin (E3 Ub ligase in eukaryotes and ClpS in eubacteria), and the involvement of ATP-dependent proteases (the 26S proteasome complex in eukaryotes and the proteasome-like ClpAP in eubacteria). Furthermore, in both systems, an aminoacyl-tRNA-protein transferase (R-transferase in eukaryotes and L/F-transferase in eubacteria) conjugates a primary destabilizing residue to the substrate's secondary destabilizing N-terminal residue. These similarities between the N-end rule pathways in the two kingdoms imply that these pathways and their components share a common origin. However, in contrast to the sequence similarity between the eukaryotic E3 Ub ligase and the eubacterial ClpS (Lupas and Koretke, 2003) , no significant sequence similarity exists between the eukaryotic R-transferase and the eubacterial L/F-transferase.
E. coli L/F-transferase was identified about four decades ago (Kaji et al, 1965a, b) . Biochemical studies revealed that E. coli L/F-transferase catalyzes the transfer of Leu and Phe, and Met and Trp less efficiently, using the cognate aminoacyl-tRNAs (Kaji et al, 1965a, b; Horinishi et al, 1975; Abramochkin and Shrader, 1996) to the N-terminal Arg and Lys of acceptor proteins (Soffer, 1973) . It was also reported that the anticodon of the aminoacyl-tRNA is not a determinant for the enzyme recognition, but that the single-stranded acceptor region of the aminoacyl-tRNA is required for the L/F-transferase activity (Abramochkin and Shrader, 1996) . However, the detailed molecular basis for the recognition of the aminoacyl moiety of an aminoacyl-tRNA by L/F-transferase has remained obscure.
Here, we have determined the crystal structures of E. coli L/F-transferase and its complex with puromycin, an analog of the aminoacyl-tRNA. The structure of this complex, together with extensive biochemical mutational studies, revealed the mechanism by which L/F-transferase specifically recognizes the aminoacyl-moiety of aminoacyl-tRNAs. Based on the current structure, we also present a model of the L/F-transferase complex with tRNA and substrate proteins bearing an N-terminal Arg or Lys residue.
Results and discussion
Overall architecture of E. coli L/F-transferase and structural similarity with the FemABX enzyme family The E. coli L/F-transferase was overexpressed in E. coli and crystallized. The apo structure was initially solved by multi-wavelength anomalous dispersion (MAD), using the selenomethionine-labeled protein, and the native structure was refined to an R factor of 27.5% (R free of 22.2%) using reflections up to 2.4 Å resolution. Subsequently, the data sets were collected from crystals soaked in puromycin. The structure of the complex with puromycin was refined to an R factor of 27.5% (R free of 22.5%) up to 2.8 Å resolution (Supplementary Table 1 ).
E. coli L/F-transferase forms a compact structure and consists of two domains: an NH 2 -terminal domain (aminoacid residues 3-62) and a COOH-terminal domain (aminoacid residues 63-232) ( Figure 1A ). The NH 2 -terminal domain is composed of four b-strands (b1-4) and one a-helix (a1), Domain 1  Domain 2  Domain 1  Domain 2   α1   β2 β1  β3 β4   α7   α5   α4  α2   α6   α3   β11   β5   β10   β8   β9   β7   β6   β12   α1   β2   β1   β4   β8   β7   β6   β12   β9   β10   β3   β11   α7  α4   α3   α2   α6  α5   β5   α1   β2   β1   β4   β8   β7   β6   β12   β9   β10   β3   β11   α7  α4   α3   α2   α6 whereas the COOH-terminal domain is composed of eight b-strands (b5-12) surrounded by six a-helices (a2-7) ( Figure 1B) . Puromycin, an aminoacyl-tRNA analog, binds to the cleft formed by b9, a5, and b10 in the COOH-terminal domain and by b3 in the NH 2 -terminal domain (see below) ( Figures 1A and 2) .
The COOH-terminal domain of L/F-transferase is topologically similar to domain 2 of Weissella viridescens FemX (wvFemX; Biarrotte-Sorin et al, 2004) and that of Staphylococcus aureus FemA (saFemA; Benson et al, 2002) (Figure 1C , middle and right, respectively). Both wvFemX and saFemA belong to the FemABX family (Hegde and Shrader, 2001) , containing a GCN5-related N-acetyltransferase (GNAT) fold (Sterner and Berger, 2000) (Figure 1B) , and catalyze the transfer of an amino acid to a precursor of peptidoglycan, using an aminoacyl-tRNA as a substrate. WvFemX transfers an alanine to the e-amino group of a Lys side chain using Ala-tRNA Ala as a substrate, whereas saFemA transfers a glycine to the a-amino group of a Gly main chain, utilizing Gly-tRNA Gly , to form an interpeptide bridge of the peptidoglycan. Therefore, the topological similarity between the COOH-terminal domain of L/F-transferase and the domain 2 0 s of wvFemX and saFemA may reflect the similarity of their chemical reactions, where an amino acid is transferred from an aminoacyl-tRNA to the amino group of a protein (or peptide). It is interesting to note that, although the topological and structural similarity is readily apparent between L/F-transferase and the FemABX families ( Figure 1C) , there is no significant amino-acid similarity between these enzymes, suggesting that they might have arisen from a common ancestor, but have divergently evolved.
In contrast to the topological similarity between the COOHterminal domain of L/F-transferase and the domain 2 0 s of wvFemx and saFemA, no significant topological similarity can be identified between the NH 2 -terminal domain of L/Ftransferase and the domain 1's of wvFemX and saFemA ( Figure 1C ).
Recognition of an aminoacyl-tRNA analog, puromycin, by L/F-transferase The chemical structure of puromycin is similar to that of the 3 0 -terminus of an aminoacyl-tRNA; the carboxyl group of p-methoxyphenylalanine is linked to the 3 0 -amino group of 3 0 -amino-6-N,N-dimethyladenosine by an amide bond ( Figure 3A) . The p-methoxybenzyl group and the 6-N,N-dimethyladenosine correspond to the side chain of an amino acid and the adenosine at the CCA end of an aminoacyl-tRNA, respectively.
Puromycin reportedly inhibits the activity of L/F-transferase by preventing the aminoacyl-tRNA from binding to the enzyme, suggesting that puromycin binds to the same position in L/F-transferase as the 3 0 -end of an aminoacyl-tRNA (Horinishi et al, 1975; Abramochkin and Shrader, 1996) . To elucidate the molecular basis of the recognition of the aminoacyl moiety of aminoacyl-tRNAs by L/F-transferase, apo L/ F-transferase crystals were soaked in a solution containing puromycin, and the crystal structure was determined (Supplementary Table 1 ).
The electron density corresponding to the puromycin was clearly visible in the complex structure ( Figure 3B ), with no significant structural change observed between the apo and complex structures. The puromycin binds to a cleft formed by b9, a5, and b10 in the COOH-terminal domain and b3 in the NH 2 -terminal domain ( Figure 1A ).
The p-methoxybenzyl group of puromycin is docked within a deep pocket at the bottom of the cleft ( Figure 3C and D). The pocket is composed of the side chains of several hydro- Figure 2 Sequence alignment of the L/F-transferases from E. coli (Aat_E. coli), Xylella fastidosa (Aat_X-fast; accession number ZP_00683190.1), Pseudomonas aeruginosa (Aat_P. aeru; accession number ZP_00204849.1), Synechocystis (Aat_Synech; accession number NP_440931.1), and Mesorhizobium loti (Aat_M. loti; accession number NP_102051.1). The sequence of R-transferase from Plasmodium falciparum (ATEL_P. fa; accession number NP_473045.1). The secondary structure elements of E. coli L/F-transferase are indicated above the alignment. The a-helices and b-strands in the NH 2 -terminal domain are colored blue, and those of the COOH-terminal domain are colored red and yellow, respectively, as shown in Figure 1B . phobic residues (Met144, Phe153, Leu170, Phe173, Ile185), and thus the inner surface is quite hydrophobic. The recognition of the p-methoxybenzyl group of puromycin by L/Ftransferase is achieved through a hydrophobic interaction with these amino-acid residues. The edge of the pocket is formed by the main chains of continuous residues (Gly155, Glu156, Ser157) and the side chain of Met158 ( Figure 3E ), adopting a C-shaped structure. The b-carbon of the p-methoxyphenylalanine group of puromycin is cramped by the C-shaped edge of the pocket: the side chain of Met158 and the peptide bond between Gly155 and Glu156 sandwich the b-carbon of puromycin ( Figure 3E ). The distance between the Cg of puromycin and the Ce of Met158 is 3.8 Å , and the distances between the Cb of puromycin and the Ca of Ser157 and the main chain N of Glu156 are 3.5 and 4.0 Å , respectively ( Figure 3E ).
The 6-N,N-dimethyladenine group of puromycin is stabilized mainly by a p-p stacking interaction with Trp49, which is further stabilized by a stacking interaction with Trp111 ( Figure 3D ). The hydrophobic amino-acid residues, Trp59, Phe47, and Val189, interact with the base moiety of puromycin through hydrophobic interactions, and these interactions are not specific to the 6-N,N-dimethyladenine of puromycin. The 2 0 -hydroxyl group of the ribose moiety of puromycin hydrogen bonds with the main-chain carbonyl group of Glu156 ( Figure 3D ).
Recognition mechanism of the amino-acid moiety of the aminoacyl-tRNA by L/F-transferase
The chemical structure of puromycin resembles that of the 3 0 -termini of aminoacyl-tRNAs, as described ( Figure 3A) . The reported inhibitory effect by puromycin on L/F-transferase activity might reflect the similar hydrophobic properties of the p-methoxybenzyl group of puromycin to the side chains of phenylalanine and leucine ( Figure 3A) . Moreover, the 6-N,N-dimethyladenosine corresponds to the 3 0 -terminal adenosine at position 76 in the aminoacyl-tRNAs.
To explore the detailed molecular mechanism of the recognition of the 3 0 -end of Leu-tRNA Leu or Phe-tRNA Phe by L/F-transferase, a series of site-directed mutations were introduced into the L/F-transferase residues that are proximal to puromycin, based on the present complex structure, and the activities of leucyl and phenylalanyl transfer to a-casein bearing an NH 2 -terminal Arg, from the respective aminoacyl-tRNAs, were analyzed ( Figure 4A and B) .
Mutations of hydrophobic amino-acid residues (Met144, Phe153, Leu170, Phe173, Ile185) that accommodate the p-methoxybenzyl group of puromycin (Figure 3C and D) considerably reduced the L/F-transferase activity ( Figure 4A and B). Therefore, it is reasonable to assume that the hydrophobic leucyl and phenylalanyl moieties of Leu-tRNA Leu and Phe-tRNA Phe , respectively, are recognized by this highly hydrophobic pocket of L/F-transferase. Actually, superposition of the a and b carbons of Phe and Leu onto those of puromycin revealed that the side chains of Phe and Leu can enter the hydrophobic pocket without any steric clashes ( Figure 5A and B). The corresponding amino-acid residues of L/F-transferases from other eubacteria are well conserved as hydrophobic amino-acid residues (Figure 2) . These results explain why L/F-transferase recognizes aminoacyl-tRNAs attached to hydrophobic amino acids, and excludes those coupled to hydrophilic or charged amino acids.
The b-carbon of the aminoacyl moiety of puromycin is sandwiched between the side chain of Met158 and the peptide-bond plane of Gly155-Glu156 ( Figure 3E ). Both the side chains of the leucyl and phenylalanyl moieties of the respective aminoacyl-tRNAs lack branched b-carbons ( Figures 3A, 5A, and B) . When the Ca and Cb of Ile and Val, possessing branched b-carbons, are superimposed onto those of puromycin ( Figure 5C and D) , the distances between the branched Cg2 of Ile and the carbonyl carbon of Glu156, and between the branched Cg2 of Val and the Ca of Ser157 are 2.6 and 2.5 Å , respectively. These close distances between the branched methyl groups of Ile and Val and the C-shaped edge would cause steric hindrance, thus precluding aminoacyl-tRNAs charged with b-branched amino acids, such as Ile and Val. These results explain the specificity of L/Ftransferase for amino acids bearing an unbranched b-carbon (Abramochkin and Shrader, 1996) .
For the other hydrophobic amino-acid residues, such as Ala, Pro, Trp, and Met, the size of the Ala and Pro side chains is not large enough to fit within the hydrophobic pocket (Supplementary Figure 1A and B) . On the other hand, L/Ftransferase reportedly transfers Met and Trp to proteins bearing an N-terminal Arg or Lys, although the activities are less efficient as compared with those of Leu and Phe (Kaji et al, 1965a; Abramochkin and Shrader, 1996) . Our in vitro assays using Met-tRNA Met and Trp-tRNA Trp as substrates also showed that both Met and Trp could be transferred to the NH 2 -terminal Arg of the a-casein fragment (Supplementary Figure 2D and Figure 2F) .
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[ C]Phe incorporation (relative) hydrophobic pocket is smaller than that of Leu and Phe. These findings explain the previous and present data showing that Trp and Met are incorporated into the protein by L/Ftransferase less efficiently than Leu or Phe in vitro, and that Leu and Phe are incorporated predominantly in vivo. Taken together, the hydrophobicity and size of the pocket and the confined C-shaped structure of the edge of the pocket could collaboratively discriminate Leu and Phe predominantly (and Trp and Met less efficiently), from other aminoacid residues to be transferred to acceptor proteins bearing Arg or Lys at the N-terminus. It is notable that the continuous amino-acid residues composing the C-shaped edge (Gly155-Met158) of the hydrophobic pocket are well conserved among the eubacterial L/F-transferases (Figure 2) .
The 6-N,N-dimethyladenosine of puromycin corresponds to the 3 0 -terminal adenosine residue (A76) of tRNA, as described above ( Figure 3A) . The 6-N,N-dimethyladenosine of puromycin interacts with several amino-acid residues ( Figure 3D ). The mutations of Trp49 and Trp111 drastically reduced the L/F-transferase activity (Figure 4) , suggesting that the stacking interaction between the base moiety of A76 and Trp49 and the further stabilization by Trp111 are crucial for recognition of the 3 0 -terminal nucleotide of the aminoacyl-tRNAs. This result is consistent with the previous finding that the activity of a recombinant L/F-transferase, lacking the NH 2 -terminal 78 amino acids, is significantly reduced (Ichetovkin et al, 1997) . Moreover, the mutation of Val189, which interacts with the base moiety through a hydrophobic interaction, reduced the activity, as expected (Figure 4) . The present structural and biochemical studies of L/Ftransferase (Figures 3 and 4 ) strongly suggest that the 3 0 -terminus of the aminoacyl-tRNA is recognized by the combination of the hydrophobic aminoacyl moiety recognizing pocket and the 3 0 -nucleotide recognition site, although the 3 0 -nucleotide binding site is not specific for the adenosine.
Docking model of L/F-transferase and aminoacyl-tRNA
The electrostatic potential surface of L/F-transferase reveals the highly biased distribution of charged residues ( Figure 6A , lower panel). Especially, the a2 helix in the COOH-terminal domain contains a cluster of positively charged residues (Arg76, Arg80, Lys83, and Arg84). These amino-acid residues protrude toward the solvent and are conserved among the eubacterial L/F-transferases (Figure 2) . Moreover, next to the charged region, a cleft suitable for the accommodation of the 3 0 -region of a tRNA-acceptor helix is formed by helices a5 and a6, extending toward the puromycin-binding pocket ( Figure 6A, lower and right panels) . The amino-acid residues in the NH 2 -terminal half of a5 (Asn164, Ser166, and Lys167) and Asn191 and His193 in a6 are well conserved among the eubacterial L/F-transferases (Figure 2) . Mutations of the positively charged residues in a2 (Arg76, Arg80, Lys83, and Arg84) and a6 (His193) remarkably reduced the L/F-transferase activity (Figure 4) . A comparison of the surface electrostatic potential of L/F-transferase with that of wvFemX and saFemA revealed similar distributions of positively charged amino-acid residues, in the regions corresponding to the a2 helix of L/F-transferase, and the distances between the positively charged region and the substrate-binding pocket were almost the same as those observed in L/F-transferase ( Figure 6B ).
These observations and present biochemical studies allowed us to build a tRNA docking model ( Figure 6A , upper panel). In this model, the positively charged cluster in a2 interacts with the phosphate backbone at the bottom of the tRNA D stem, whereas the phosphate backbone of the 3 0 -acceptor region interacts with the positively charged cleft, consisting of helices a5 and a6. The present tRNA docking model is consistent with the previous biochemical studies showing that L/F-transferase recognizes tRNA molecules in a sequence-independent manner, but in a manner depending on the aminoacyl moiety attached to the 3 0 -end of the tRNAs (Abramochkin and Shrader, 1996) . When C-CPm (cytidine-cytidine-puromycin) was soaked into the L/Ftransferase apo crystals, the electron density of puromycin was clearly visible, whereas that of the C-C was not. This observation also suggests that the aminoacyl-tRNA specificity of L/F-transferase is determined by the aminoacyl moiety attached to the 3 0 -terminus of the tRNA, rather than by the tRNA itself.
In the present model, the acceptor end of the tRNA might be disrupted or bent for the aminoacyl moiety to be accommodated into the pocket. In the previous complex structures of glutaminyl-tRNA synthetase and tRNA (Rould et al, 1989) and of methionyl-tRNA f Met transformylase and formylmethionyl-tRNA f Met (Schmitt et al, 1998) , the 3 0 -CCA ends of the tRNAs adopt similar bent hairpin conformation, with the base pair between 1 and 72 disrupted. E. coli tRNA Gln and tRNA f Met possess U1-A72 and C1-A72 base pairs, respectively. The weak base pair at the top of the acceptor helix enables glutaminyl-tRNA synthetase and methionyltRNA f Met transformylase to disrupt the base pair, allowing the tRNA 3 0 -end to adopt the bent conformation. Both E. coli tRNA Leu and tRNA Phe have G-C pairs at the top of the acceptor helices. It should be noted that the L/F-transferase activity is reportedly increased when a tRNA Leu isoacceptor with weaker base pairs in the acceptor helix is used as the substrate, and when the acceptor helix of Leu-tRNA Leu is disrupted by a complementary oligonucleotide (Abramochkin and Shrader, 1996) . These observations suggest that the disruption or bending of the 3 0 -acceptor region of aminoacyl-tRNAs might be required for efficient accommodation of the aminoacyl moiety into the hydrophobic pocket of L/F-transferase. The crystal structure of the archaeal leucyltRNA synthetase and tRNA Leu complex revealed that the tRNA CCA end adopts a bent conformation (Fukunaga and Yokoyama, 2005) , where the G-C pair at the top of the acceptor helix of tRNA Leu is not disrupted. Therefore, it is also possible that the 3 0 -CCA of tRNA could adopt a bent conformation by L/F-transferase, and the aminoacyl moiety of the aminoacyl-tRNA could be accommodated in the hydrophobic pocket, without the disruption of tRNA acceptor helix. It is interesting to note that the elongation factor (EF-Tu) binds to all aminoacyl-tRNAs uniformly. The uniform binding of EF-Tu to all aminoacyl-tRNAs is suggested to be ensured by combinational recognition of amino acid and tRNA moieties of aminoacyl-tRNAs (Ibba, 2001; LaRiviere et al, 2001 ). At present, it is not clear whether similar principle can be applied to the binding of aminoacyl-tRNA to L/F-transferase. The further experimental studies are required to clarify this point.
As shown in Figure 6C , our tRNA-docking model allows the simultaneous binding of EF-Tu to the tRNA. An in vitro UV crosslinking experiment showed that the ternary complex of L/F-transferase, EF-Tu, and aminoacyl-tRNA is not formed, and that EF-Tu competes with L/F-transferase for binding with the aminoacyl-tRNA (Supplementary Figure  3A and B) . The initial rate of L/F-transferase activity is reduced in the presence of an excess amount of EF-Tu, suggesting that the recognition of aminoacyl-tRNAs by L/F-transferase and EF-Tu is competitive (Supplementary Figure 3C and D) . Therefore, L/F-transferase might overcome the competition with EF-Tu in the uptake of the aminoacyl-tRNA by using a different binding site in the tRNA, which does not overlap with the EF-Tu binding site. The transfer of aminoacyl-tRNAs between L/F-transferase and EF-Tu does not require full dissociation of the tRNA molecule, and thus only the structural change of the acceptor end of the tRNA might be required, as shown in Figure 6C .
Recognition of an acceptor protein bearing Lys or Arg at the N-terminus L/F-transferase catalyzes the transfer of the aminoacyl moiety of Leu-tRNA Leu or Phe-tRNA Phe to the amino group of an acceptor protein bearing Lys or Arg at its NH 2 -terminus. This enzymatic activity is similar to peptide-bond formation by ribosomes. Our extensive efforts to locate the acceptor peptides, such as the a-casein fragment peptide (RYLGYL) and other peptides (RGDS and RFDS), by soaking the L/Ftransferase crystals into solutions containing both puromycin and these acceptor peptides, were unsuccessful, although the a-casein fragment peptide can accept Leu from Leu-tRNA Leu and Phe from Phe-tRNA
Phe by L/F-transferase in vitro (Supplementary Figure 2) ; only the electron density corresponding to puromycin was visible (data not shown).
In the complex structure of L/F-transferase with puromycin, the loop region between a3 and a4 occupies the space where the acceptor peptide would enter to approach the puromycin. This might explain why the acceptor peptides were not visible in our structure. The binding of aminoacyltRNAs to L/F-transferase probably induces a global conformational change accompanied by the movement of the loop region between a3 and a4. As a result, the NH 2 -terminus of acceptor peptides can approach the aminoacyl moiety of the aminoacyl-tRNAs (Supplementary Figure 4A) .
Our functional studies showed that the mutation of Glu156 abolished and that of Gln188 significantly impaired the L/Ftransferase activity (Figure 4) . As the side chains of these residues do not interact with the puromycin directly, they might be involved in the interaction with the acceptor protein. We can speculate here that the terminal carboxyl groups of Glu156 and Gln188 interact with the positively charged side chain of the NH 2 -terminal Arg or Lys of the acceptor protein, to fix the amino group of the N-terminal residue in the vicinity of the aminoacyl bond of the aminoacyl-tRNA, thus facilitating peptide-bond formation. The replacement of Glu156 with Lys or Arg abolished the L/F-transferase activity, whereas that of Glu156 with Asp did not impair the activity completely (Supplementary Figure 4B) . Therefore, it is possible that an electrostatic interaction between the positively charged Arg or Lys at the NH 2 -terminus of the substrate proteins and the negatively charged side chain of Glu156 of L/F-transferase is essential for substrate protein recognition.
To elucidate the exact molecular mechanism of peptidebond formation by L/F-transferase, further structural analyses using more authentic substrates, such as an aminoacyl-tRNA and a transition state analog of the substrates, are now underway.
Concluding remarks
Recent phylogenetic and biochemical analyses have revealed the presence of new types of aminoacyl-tRNA protein transferases. In the human pathogen Vibrio vulnificus, a eubacterial protein transferase, named Bpt, was identified (Graciet et al, 2006) . Bpt is a homolog of the eukaryotic R-transferase, but it conjugates leucine to the N-terminal Asp or Glu. Moreover, in the eukaryotic pathogen Plasmodium falciparum, a eukaryotic protein transferase, named ATEL1, was also identified (Graciet et al, 2006) . ATEL1 is a homolog of the eubacterial L/F-transferase (Figure 2 ), but its activity is the same as that of eukaryotic R-transferases. Therefore, the specificities for the donor and acceptor amino acids, as well as the hierarchic structure of the N-end rule, of aminoacyl-tRNA-protein transferases are diverse among living organisms. It is noteworthy that the amino-acid residues comprising the C-shaped edge of the hydrophobic pocket in L/F-transferase ( Figure 3E ) are not conserved in ATEL1 (Figure 2 ). In contrast, the cluster of positively charged residues, which might interact with the D stem region of the aminoacyl-tRNA, are conserved in ATEL1 (Figure 2) , suggesting that the tRNA-binding mode of ATEL1 might be similar to that of L/F-transferase (Figure 6 ). Further structural analyses of various aminoacyl-tRNA protein transferases will provide the structural basis for the evolution and the physiological meaning of the N-end rule protein degradation pathway in living organisms.
Materials and methods

Purification and crystallization of L/F-transferase
The E. coli aat gene, encoding L/F-transferase, was PCR-amplified from the genomic DNA and cloned into the pET15b vector (Novagen) between the NdeI and BamHI sites. The recombinant L/F-transferase contains additional vector-encoded histidine residues (MGSSHHHHHHSSGLVPRGSH) at its N-terminus for affinity purification. E. coli BL21(DE3) Codon Plus (Stratagene) was transformed by the plasmid, inoculated in LB medium containing 50 mg/ml ampicillin and 20 mg/ml chloramphenicol, and grown at 371C until the A 600 reached 0.8. The expression of L/F-transferase was induced by the addition of IPTG (isopropyl-b-D thiogalactopyranoside) to a 0.1 mM concentration for 12 h at 251C. The cells were harvested, sonicated in a buffer containing 50 mM Tris-HCl, pH 6.8, 500 mM KCl, 6 mM b-mercaptoethanol, 10 mM imidazole and 5% (w/w) glycerol (buffer A), and centrifuged at 10 000 g for 30 min at 41C. The clear supernatant was applied to a 5 ml Ni 2 þ attached Hi-trap chelating column (GE Healthcare Bio-Sciences) equilibrated with buffer A, which was washed with 200 ml of buffer A. The protein was eluted with a 75 ml linear gradient of imidazole (10-500 mM) in buffer A. The fractions containing L/F-transferase were pooled and concentrated by NH 4 (SO 4 ) 2 precipitation. The pellet was dissolved in a buffer containing 50 mM Tris-HCl, pH 8.0, and 10 mM b-mercaptoethanol, and was dialyzed against 2 l of buffer, containing 50 mM Tris-HCl, pH 8.0, 100 mM NH 4 (SO 4 ) 2 , and 10 mM b-mercaptoethanol (buffer B), at 41C overnight. The solution was applied to a 5 ml Hi-Trap Q column (GE Healthcare Bio-Sciences) equilibrated with buffer B. The flow-through fractions were collected and concentrated to 5 mg/ml. The purity of L/Ftransferase was 495%, as judged by SDS-PAGE, and about 3 mg of L/F-transferase was obtained per liter of LB. The selenomethionine L/F-transferase derivative was expressed in the methionine auxotrophic E. coli B834 strain and was purified as described above.
Data collection, structure determination, and structural refinement of L/F-transferase For the crystallization of L/F-transferase, 1 ml of protein solution (5 mg/ml) was mixed with 1 ml of crystallization solution, containing 50 mM HEPES, pH 8.0, and 0.7 M trisodium tartrate (reservoir A), and the drop solution was equilibrated against reservoir A at 201C by the hanging drop vapor diffusion method (condition A). L/F-transferase was also crystallized under different conditions, in which the protein solution was mixed with a solution containing 50 mM HEPES, pH 8.1, 0.2 M trisodium citrate, and 17% (v/v) polyethylene glycol 3550 (reservoir B), and the drop solution was equilibrated against reservoir B (condition B).
For structure determination, three data sets for the MAD method with the selenomethionine derivative were collected at the beamline BL41XU at SPring-8 (Harima, Japan), and the data set of the native crystal were collected at BL-5A and MW12 at KEK (Tsukuba, Japan). The crystals were cryo-protected with 20% (v/v) ethylene glycol, and were flash-frozen in a 100 K nitrogen stream. All of the data were processed using the program HKL2000 (Otwinowski and Minor, 1997) . The native crystals from conditions A and B belong to the space group P2 1 2 1 2, with a ¼ 114.0, b ¼ 129.6, c ¼ 38.8 Å , and contain two molecules in the asymmetric unit cell. The selenomethionine crystal showed the same space group and unit cell parameters of a ¼ 116.5, b ¼ 129.8, c ¼ 39.0 Å . The data set at the peak wavelength up to 2.80 Å resolution was used for locating the selenium atoms with the program SnB (Weeks and Miller, 1999) , and 14 peaks were picked out of 16 atoms in the asymmetric unit. An initial phase set was calculated by the MAD method, using data to 2.80 Å resolution, with the program SHARP (de La Fortelle and Bricogne, 1997), and density modification with solvent flattening and NCS averaging was performed using the program DM (CCP4, 1994; Cowtan, 1994) . A model with two L/F-transferase molecules in the asymmetric unit was built using the program XFIT (McRee, 1999) , and was refined with the native data by the program CNS (Brunger et al, 1998) . For the preparation of the complex with puromycin, a soaking solution containing all of the solutes of condition A and 5 mM puromycin was used. A native crystal crystallized under condition A was soaked in the soaking solution for 30 min, and after the diffraction data of the complex crystal were collected and processed, the model structure was refined as described above.
In vitro aminoacyl-transfer assay
Mutations were introduced into the L/F-transferase overexpression plasmid by site-directed mutagenesis, and the mutant enzymes were expressed and purified as described above. E. coli tRNA Phe and tRNA Leu were synthesized by T7 RNA polymerase in vitro using the linearized pT7trnaF and pT7trnaL plasmids, which encode the tRNA Phe and tRNA Leu genes downstream of the T7 promoter, respectively. The transcripts were fractionated by anion-exchange chromatography. The assays for leucine (or phenylalanine) transfer onto the amino group of the a-casein fragment (Sigma) were carried out in a buffer containing 50 mM Tris-HCl, pH 8.0, 100 mM KCl, 10 mM Mg(OAc) 2 , 1 mM DTT, 2 mM ATP, 0.5 mM tRNA Leu (or 1.0 mM tRNA Phe ), 16.4 mM [ 14 C]Leu (11.3 GBq/mmol) (or 11.0 mM [ 14 C]Phe, 17 GBq/mmol), 10 mM a-casein, an excess amount of leucyl-tRNA synthetase (or phenylalanyl-tRNA synthetase), and 0.12 mM L/Ftransferase (or 0.06 mM L/F-transferase). After a 7 min (or a 4 min) incubation at 371C, the reactions were stopped by adding SDS-PAGE loading buffer and were incubated at 1001C for 8 min, to deacylate the aminoacyl-tRNA. The mixtures were separated by 15% SDS-PAGE, dried, and visualized with a BAS-5000 bioimaging analyzer (Fuji Film) . The intensities of the 14 C-labeled a-casein were quantified. Under these assay conditions, the reactions proceeded in the linear range; therefore, the assay conditions used here are sensitive enough to evaluate the effect of each mutation on the L/F-transferase activity.
Supplementary data
Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).
